(Q38448285)

3 September 2017

1 reference

title

Prevention of Clostridium difficile Infection With Probiotics (English)

1 reference

3 September 2017

0 references

Clostridium difficile

object named as

Clostridium difficile

1 reference

Charlesnika T Evans

1

1 reference

3 September 2017

Stuart Johnson

series ordinal

2

1 reference

3 September 2017

language of work or name

English

0 references

publication date

1 May 2015

1 reference

Clinical Infectious Diseases

3 September 2017

published in

1 reference

3 September 2017

volume

60 Suppl 2

1 reference

3 September 2017

page(s)

S122-8

1 reference

Multistate point-prevalence survey of health care-associated infections

3 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV138

Decreased diversity of the fecal Microbiome in recurrent Clostridium difficile-associated diarrhea

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV138

Is primary prevention of Clostridium difficile infection possible with specific probiotics?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV138

Probiotic therapy for the prevention and treatment of Clostridium difficile-associated diarrhea: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV138

Meta-analysis of probiotics for the prevention of antibiotic associated diarrhea and the treatment of Clostridium difficile disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV138

Probiotics for the prevention of Clostridium difficile-associated diarrhea: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV138

Effect of a fermented milk combining Lactobacillus acidophilus Cl1285 and Lactobacillus casei in the prevention of antibiotic-associated diarrhea: a randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV138

The lack of therapeutic effect of Saccharomyces boulardii in the prevention of antibiotic-related diarrhoea in elderly patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV138

Use of probiotic Lactobacillus preparation to prevent diarrhoea associated with antibiotics: randomised double blind placebo controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV138

Clostridium difficile infections in China.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV138

Overview of Clostridium difficile infection: implications for China

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV138

Prophylactic Lactobacillus GG reduces antibiotic-associated diarrhea in children with respiratory infections: a randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV138

Efficacy and safety of Saccharomyces boulardii in prevention of antibiotic-associated diarrhoea due to Helicobacterpylori eradication

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV138

Saccharomyces boulardii in the prevention of antibiotic-associated diarrhoea in children: a randomized double-blind placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV138

Intake of Lactobacillus plantarum reduces certain gastrointestinal symptoms during treatment with antibiotics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV138

Feasibility and tolerability of probiotics for prevention of antibiotic-associated diarrhoea in hospitalized US military veterans

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV138

Efficacy and safety of Saccharomyces boulardii in the 14-day triple anti-Helicobacter pylori therapy: a prospective randomized placebo-controlled double-blind study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV138

Saccharomyces boulardii for the prevention of antibiotic-associated diarrhea in adult hospitalized patients: a single-center, randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV138

Probiotic prophylaxis of ventilator-associated pneumonia: a blinded, randomized, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV138

Lactobacilli and bifidobacteria in the prevention of antibiotic-associated diarrhoea and Clostridium difficile diarrhoea in older inpatients (PLACIDE): a randomised, double-blind, placebo-controlled, multicentre trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV138

A Lactobacillus casei Shirota probiotic drink reduces antibiotic-associated diarrhoea in patients with spinal cord injuries: a randomised controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV138

A randomized placebo-controlled trial of Saccharomyces boulardii in combination with standard antibiotics for Clostridium difficile disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV138

Breaking the cycle: treatment strategies for 163 cases of recurrent Clostridium difficile disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV138

Lactobacillus plantarum 299v for the treatment of recurrent Clostridium difficile-associated diarrhoea: a double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV138

Evaluation of an oral suspension of VP20621, spores of nontoxigenic Clostridium difficile strain M3, in healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV138

21 January 2018

Identifiers

DOI

10.1093/CID/CIV138

1 reference

3 September 2017

1 reference